Ann Surg Oncol

1. SHIMIZU H, Kurashima K, Fukami T, Miyoshi T, et al
   ASO Author Reflections: Glutaredoxin 2 has Potential as a Therapeutic Target for Colon Cancer.
   Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18632.
   

   >> Share

   
   

   
   Anticancer Res

2. HOSOKAWA A, Yamada R, Otsuki Y, Tamura H, et al
   Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer.
   Anticancer Res. 2025;45:5069-5076.
   

   >> Share

   
   
3. KITAGUCHI D, Enomoto T, Hoshiai S, Furuya K, et al
   Preoperative Risk Analysis for Postoperative Recurrence in Locally Advanced Rectal Cancer Following Chemoradiotherapy.
   Anticancer Res. 2025;45:5147-5157.
   

   >> Share

   
   
4. KOTAKE Y, Tanigawa Y, Ikenaga H, Kitagawa T, et al
   OIP5-AS1 Positively Regulates the Proliferation of Colorectal Cancer Cells by Repressing Apoptosis.
   Anticancer Res. 2025;45:4783-4790.
   

   >> Share

   
   
5. KIM MW, Kim D, Lee SE, Ahn J, et al
   JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway.
   Anticancer Res. 2025;45:4987-5000.
   

   >> Share

   
   
6. MARUTA H, Noda K, Tominaga T, Hashimoto S, et al
   Efficacy and Safety of Robotic Surgery for Bulky Colorectal Tumors.
   Anticancer Res. 2025;45:5139-5146.
   

   >> Share

   
   
7. SHIMASAKI M, Kiyozumi Y, Ohmura R, Matsuishi K, et al
   Pathological Complete Response in Locally-advanced MSI-H/dMMR Sigmoid Colon Cancer Treated With Pembrolizumab and Abdominal Reconstruction.
   Anticancer Res. 2025;45:5239-5246.
   

   >> Share

   
   
8. TSAI YF, Wu MH, Lin TC, Yueh TC, et al
   Contribution of Xeroderma Pigmentosum Complementation Group C Genotypes to Colorectal Cancer in Taiwanese.
   Anticancer Res. 2025;45:4751-4763.
   

   >> Share

   
   

   
   BMC Cancer

9. WEI H, Yuan L, Li Y, Xia Y, et al
   Global status and attributable risk factors of esophageal, stomach, colorectal cancers in adolescents and young adults: global burden of disease 2021 study analysis.
   BMC Cancer. 2025;25:1682.
   

   >> Share

   
   
10. PRADHAN P, Chophel U, Wangmo S, Dorji T, et al
    Clinical and epidemiological profile of patients with colorectal cancer in Bhutan: a cross-sectional study.
    BMC Cancer. 2025;25:1673.
    

    >> Share

    
    

    
    BMC Gastroenterol

11. HAM DY, Lee JG, Ahn CI, Kae SH, et al
    Artificial intelligence-assisted colonoscopy improves adenoma detection rates in routine colonoscopy practice: a single-center, retrospective, propensity score-matched study with concurrent controls.
    BMC Gastroenterol. 2025;25:755.
    

    >> Share

    
    
12. WAN Y, Zou MS, Li D, Li Y, et al
    Enhancing explainability of random survival forests in predicting stent patency risk for malignant colonic obstruction.
    BMC Gastroenterol. 2025;25:754.
    

    >> Share

    
    
13. AKTEPE OH, Kurtulan O, Dama PE, Yildirim EC, et al
    Prognostic importance of CD47 expression on survival of colorectal cancer.
    BMC Gastroenterol. 2025;25:757.
    

    >> Share

    
    
14. LI Y, Zhuang M, Mei S, Tang J, et al
    Neoadjuvant combination immunotherapy for colorectal cancer: clinical and molecular predictors of pathological complete response and safety assessment.
    BMC Gastroenterol. 2025;25:769.
    

    >> Share

    
    

    
    Cancer Lett

15. HAQUE PS, Paris SL, Souza RF, Onyiah JC, et al
    Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis.
    Cancer Lett. 2025 Oct 28:218104. doi: 10.1016/j.canlet.2025.218104.
    

    >> Share

    
    

    
    Clin Cancer Res

16. YEH C, Artz O, Zhang H, Karnoub ER, et al
    Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancer.
    Clin Cancer Res. 2025 Oct 30. doi: 10.1158/1078-0432.CCR-25-2566.
    

    >> Share

    
    

    
    Dis Colon Rectum

17. DO M, Kim S, Lee WY, Yun SH, et al
    Incidence and Risk Factors of Pulmonary Metastasis as the Initial Site of Metastasis After Surgical Resection for Rectal Cancer by TNM Stage.
    Dis Colon Rectum. 2025;68:1285-1295.
    

    >> Share

    
    
18. HEWITT AJ, Freeman MJ, Hayden DM, Carchman EH, et al
    Evaluation of Anal Cancer Screening Practices Among a National Cohort of Veterans With HIV.
    Dis Colon Rectum. 2025;68:1276-1284.
    

    >> Share

    
    
19. MUI M, Kong JCH, Michael M, Ramsay R, et al
    Role of Neoadjuvant Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review of Currently Available Studies.
    Dis Colon Rectum. 2025;68:1265-1274.
    

    >> Share

    
    
20. KUO CY, Lee CY, Kung CH, Ngu JC, et al
    A Predictive Model for Anastomotic Complications After Sphincter-Preserving Surgery for Rectal Cancer: Integrating Clinical and Anatomical Risk Factors.
    Dis Colon Rectum. 2025;68:1296-1306.
    

    >> Share

    
    

    
    Int J Cancer

21. JIANG R, Xing S, Wang X, Chen S, et al
    Association between TyG-related indices and colorectal cancer risk: A prospective cohort study.
    Int J Cancer. 2025 Oct 31. doi: 10.1002/ijc.70222.
    

    >> Share

    
    

    
    Int J Colorectal Dis

22. SAITO A, Yokoyama Y, Uchino M, Ikeuchi H, et al
    Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification.
    Int J Colorectal Dis. 2025;40:223.
    

    >> Share

    
    
23. CHEN ZW, Xu T, Yin ZH, Li QF, et al
    Electroacupuncture for chemotherapy-induced gastrointestinal symptoms in colorectal cancer: protocol for a multicenter, three-arm, randomized controlled trial.
    Int J Colorectal Dis. 2025;40:221.
    

    >> Share

    
    

    
    J Clin Oncol

24. ASSENAT E, Ben Abdelghani M, Gourgou S, Perrier H, et al
    Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
    J Clin Oncol. 2025 Oct 28:JCO2502239. doi: 10.1200/JCO-25-02239.
    

    >> Share

    
    
25. OWENS CA, Ludmir EB, Liu Q, Qiu W, et al
    Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report.
    J Clin Oncol. 2025;43:3403-3421.
    

    >> Share

    
    

    
    J Surg Oncol

26. ERKAYA M, Karahan S, Oruc M, Amarnath SR, et al
    The Impact of Intraoperative Radiotherapy on Margin Positive Locally Advanced Rectal Cancer: A Propensity-Matched Analysis of The National Cancer Database.
    J Surg Oncol. 2025;132:1257-1265.
    

    >> Share

    
    

    
    Oncol Rep

27. HOU X, Wang Y, Chen Y, Zhong P, et al
    LRRC59 inhibits perk pathway?induced apoptosis and promotes cell proliferation, migration and invasion in colorectal cancer cells.
    Oncol Rep. 2026;55:5.
    

    >> Share

    
    

    
    PLoS One

28. LAVRINENKO V, Donskaya I, Popov V, Litau E, et al
    Phenotypic profiling of small molecules using cell painting assay in HCT116 colorectal cancer cells.
    PLoS One. 2025;20:e0334025.
    

    >> Share

    
    
29. LIU Q, Lei Y, Liu Z, Han J, et al
    Integrative GWAS and RNA-Seq analysis for target identification and virtual drug screening in colorectal cancer.
    PLoS One. 2025;20:e0333179.
    

    >> Share

    
    

    
    World J Surg

30. XU W
    Acute Presentations of Colorectal Cancer: An International Prospective Snapshot on Management and Outcomes.
    World J Surg. 2025 Oct 28. doi: 10.1002/wjs.70106.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share